These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 24338982

  • 1. Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review.
    Liang J, Higgins T, Ishman SL, Boss EF, Benke JR, Lin SY.
    Laryngoscope; 2014 Jun; 124(6):1308-13. PubMed ID: 24338982
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis.
    Raynor EM, Butler A, Guill M, Bent JP.
    Arch Otolaryngol Head Neck Surg; 2000 May; 126(5):581-3. PubMed ID: 10807324
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dornase alfa for cystic fibrosis.
    Jones AP, Wallis C.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD001127. PubMed ID: 20238314
    [Abstract] [Full Text] [Related]

  • 7. Surgical and medical management of chronic rhinosinusitis in pediatric cystic fibrosis patients: Impact on olfactory symptoms.
    Shan HD, Vilarello BJ, Jacobson PT, Tervo JP, DiMango E, Gudis DA, Overdevest JB.
    Int J Pediatr Otorhinolaryngol; 2024 Apr 17; 179():111898. PubMed ID: 38452513
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial.
    Mainz JG, Schumacher U, Schädlich K, Hentschel J, Koitschev C, Koitschev A, Riethmüller J, Prenzel F, Sommerburg O, Wiedemann B, Staab D, Gleiber W, Fischer R, Beck JF, Arnold C, Cooperators.
    J Cyst Fibros; 2016 Nov 17; 15(6):e57-e66. PubMed ID: 27267518
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of dornase alfa in the treatment of cystic fibrosis.
    Cramer GW, Bosso JA.
    Ann Pharmacother; 1996 Jun 17; 30(6):656-61. PubMed ID: 8792953
    [Abstract] [Full Text] [Related]

  • 12. Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change.
    VanDevanter DR, Craib ML, Pasta DJ, Millar SJ, Morgan WJ, Konstan MW, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Pediatr Pulmonol; 2018 Jan 17; 53(1):43-49. PubMed ID: 29064184
    [Abstract] [Full Text] [Related]

  • 13. Chronic Rhinosinusitis in Patients with Cystic Fibrosis.
    Hamilos DL.
    J Allergy Clin Immunol Pract; 2016 Jan 17; 4(4):605-12. PubMed ID: 27393775
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.
    Goa KL, Lamb H.
    Pharmacoeconomics; 1997 Sep 17; 12(3):409-22. PubMed ID: 10170464
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure.
    Lal D, Scianna JM, Stankiewicz JA.
    Am J Rhinol Allergy; 2009 Sep 17; 23(4):396-400. PubMed ID: 19671254
    [Abstract] [Full Text] [Related]

  • 17. [Possibilities of using recombinant human deoxyribonuclease I in otorhinolaryngology].
    Eremeeva KV, Svistushkin VM, Sinkov EV, Mironova AR, Sobolev VP.
    Vestn Otorinolaringol; 2023 Sep 17; 88(2):59-66. PubMed ID: 37184556
    [Abstract] [Full Text] [Related]

  • 18. Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Johnson CA, Butler SM, Konstan MW, Breen TJ, Morgan WJ.
    J Pediatr; 1999 Jun 17; 134(6):734-9. PubMed ID: 10356143
    [Abstract] [Full Text] [Related]

  • 19. Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options.
    Krajewska J, Zub K, Słowikowski A, Zatoński T.
    Eur Arch Otorhinolaryngol; 2022 Jan 17; 279(1):1-24. PubMed ID: 34296343
    [Abstract] [Full Text] [Related]

  • 20. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
    Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M.
    Arch Pediatr; 1998 Apr 17; 5(4):371-7. PubMed ID: 9759155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.